BioSpecifics Technologies Corporation
35 Wilbur Street
Lynbrook
New York
11563-2358
United States
Tel: 516-593-7000
Fax: 516-593-7010
Website: http://www.biospecifics.com/
219 articles about BioSpecifics Technologies Corporation
-
BioSpecifics Technologies Corporation Announces Formal Pricing Of XIAFLEX For The Treatment Of Dupuytren's Contracture In Japan
8/31/2015
-
BioSpecifics Technologies Corporation Announces Board Authorization Of Up To $2.5 Million Stock Repurchase Program
8/18/2015
-
BioSpecifics Technologies Corporation Reports Second Quarter 2015 Financial Results
8/11/2015
-
BioSpecifics Technologies Corporation To Report Second Quarter 2015 Financial Results On Monday, August 10, 2015
8/4/2015
-
BioSpecifics Technologies Corporation Announces Approval Of XIAFLEX In Japan For The Treatment Of Dupuytren's Contracture
7/20/2015
-
BioSpecifics Technologies Corporation To Present At The Jefferies and Co. 2015 Healthcare Conference
5/26/2015
-
BioSpecifics Technologies Corporation Reports Presentation Of First Ever Treatment Guidelines For Peyronie's Disease And XIAFLEX Efficacy Data At AUA 2015 Annual Meeting
5/20/2015
-
BioSpecifics Technologies Corporation To Present At The 2015 UBS Global Healthcare Conference
5/11/2015
-
BioSpecifics Technologies Corporation Reports First Quarter 2015 Financial Results
5/11/2015
-
BioSpecifics Technologies Corporation To Report First Quarter 2015 Financial Results On Monday, May 11, 2015
5/4/2015
-
BioSpecifics Technologies Corporation Announces Appointment Of Jennifer Chao and Jyrki Mattila, M.D., Ph.D. To Board Of Directors
4/22/2015
-
BioSpecifics Technologies Corporation To Present At The 14th Annual Needham Healthcare Conference
4/8/2015
-
BioSpecifics Technologies Corporation Reports Fourth Quarter And Full Year 2014 Financial Results
3/13/2015
-
BioSpecifics Technologies Corporation To Host Conference Call To Report Fourth Quarter And Full Year 2014 Financial Results On Friday, March 13, 2015
3/6/2015
-
BioSpecifics Technologies Corporation Announces Presentations At Upcoming Investor Conferences
2/25/2015
-
BioSpecifics Technologies Corporation Announces Approval Of XIAPEX® In The EU For The Treatment Of Peyronie's Disease
2/2/2015
-
BioSpecifics Technologies Corporation Announces Positive Opinion By CHMP For XIAPEX® For The Treatment Of Peyronie's Disease
12/23/2014
-
BioSpecifics Technologies Corporation Announces New Data On XIAFLEX For Peyronie's Disease Presented At SMSNA Scientific Meeting
11/21/2014
-
BioSpecifics Technologies Corporation To Present At The Stifel 2014 Healthcare Conference
11/13/2014
-
BioSpecifics Technologies Corporation Third Quarter 2014 Financial Results
11/10/2014